Supporting the recommended paediatric dosing regimen for rufinamide in Lennox-Gastaut syndrome using clinical trial simulation.
about
Rufinamide for pediatric patients with Lennox-Gastaut syndrome: a comprehensive overview.Impact of disease, drug and patient adherence on the effectiveness of antiviral therapy in pediatric HIV.Lennox-Gastaut syndrome: An overview.Dose selection using a semi-mechanistic integrated glucose-insulin-glucagon model: designing phase 2 trials for a novel oral glucokinase activator.
P2860
Supporting the recommended paediatric dosing regimen for rufinamide in Lennox-Gastaut syndrome using clinical trial simulation.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Supporting the recommended pae ...... ing clinical trial simulation.
@en
Supporting the recommended pae ...... ing clinical trial simulation.
@nl
type
label
Supporting the recommended pae ...... ing clinical trial simulation.
@en
Supporting the recommended pae ...... ing clinical trial simulation.
@nl
prefLabel
Supporting the recommended pae ...... ing clinical trial simulation.
@en
Supporting the recommended pae ...... ing clinical trial simulation.
@nl
P2093
P2860
P1476
Supporting the recommended pae ...... ing clinical trial simulation.
@en
P2093
D J Critchley
M Marchand
P2860
P2888
P304
P356
10.1007/S10928-009-9146-4
P577
2010-02-01T00:00:00Z